The Antibody Society maintains a comprehensive list of approved antibody therapeutics and those in regulatory review in the European Union (EU) or United States (US).

This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate …

As Figure 1 shows, the number of MAb products approved for commercial sale in the United States and Europe has grown significantly, with three to five new products approved each year between 2010 …

Jun 2, 2025 · A collection of biological approval information organized by year and regulatory authorities.

The CRI Anna-Maria Kellen Clinical Accelerator team has tracked the FDA approval timeline of active immunotherapies, noting both their increase in frequency and gradually expanding range of cancer …

The Antibody Society continuously collects data for approved antibody therapeutics and those in regulatory review in any country. A searchable table of this data is below.

19 nonclinical safety assessments of monoclonal antibodies that recognize a single molecular target, 20 referred to as monospecific antibodies. Most antibodies are pharmacologically active in

Jan 12, 2017 · Therapeutic monoclonal antibodies approved or in review in the European Union or the United States The Antibody Society maintains a comprehensive table of approved ant. body …

In 2020, despite the impact of COVID 19 pandemic, FDA approved 13 therapeutic antibodies. This mini-review focuses briefly on the characteristics of 13 therapeutic antibodies approved in 2020 by FDA …

Seven of the 15 approvals were for recombinant proteins, including 2 monoclonal antibodies. All approvals except 3 (Collagenase; Glucocerebrosidase, rDNA/Shire; Pancrelipase/J&J; Glucosidase, …